| Literature DB >> 26288695 |
Xiaojing Wang1, Minghua Sun1, Connie New1, Spencer Nam1, Wesley P Blackaby1, Alastair J Hodges1, David Nash1, Mizio Matteucci1, Joseph P Lyssikatos1, Peter W Fan1, Suzanne Tay1, Jae H Chang1.
Abstract
Time-dependent inhibition (TDI) of cytochrome P450 (CYP) enzymes may incur serious undesirable drug-drug interactions and in rare cases drug-induced idiosyncratic toxicity. The reactive metabolites are often generated through multiple sequential biotransformations and form adducts with CYP enzymes to inactivate their function. The complexity of these processes makes addressing TDI liability very challenging. Strategies to mitigate TDI are therefore highly valuable in discovering safe therapies to benefit patients. In this Letter, we disclose our simplified approach toward addressing CYP3A TDI liabilities, guided by metabolic mechanism hypotheses. By adding a methyl group onto the α carbon of a basic amine, TDI activities of both the truncated and full molecules (7a and 11) were completely eliminated. We propose that truncated molecules, albeit with caveats, may be used as surrogates for full molecules to investigate TDI.Entities:
Keywords: CYP3A; Pim kinases; TDI; metabolic mechanism
Year: 2015 PMID: 26288695 PMCID: PMC4538442 DOI: 10.1021/acsmedchemlett.5b00191
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345